thirty out-patients with endoscopically assessed , active duodenal ulcer of mild to moderate intensity were randomly assigned to 8-weeks ' treatment with either antacids ( 0.8 g/day each of aluminium hydroxide and magnesium hydroxide ) , triletide ( 1.5 g/day ) or a combination of the two treatments .
C0013295
duodenal ulcer
C0024476
magnesium hydroxide